Pioglitazone Metformin Complex Improves Polycystic Ovary Syndrome Comorbid Psychological Distress via Inhibiting NLRP3 Inflammasome Activation: A Prospective Clinical Study

Table 1

Baseline data.

	Placebo ()^a	M ()^a	PM ()^a
Age
BMI
Marital status, n (%)	Single: 7 (33.3%), married: 13 (61.9%), divorced: 1 (4.8%)	Single: 8 (30.7%), married: 15 (57.7%), divorced: 3 (11.6%)	Single: 8 (28.6%), married: 18 (64.3%), divorced: 2 (7.1%)
Level of education, n (%)	Under high school: 1 (4.7%), diploma: 1 (4.7%), higher diploma: 19 (90.6%)	Under high school: 1 (3.8%), diploma: 1 (3.8%), higher diploma: 24 (92.4%)	Under high school: 1 (3.5%), diploma: 1 (3.5%), higher diploma: 36 (93.0%)

BMI: body mass index; PCOS: polycystic ovary syndrome. ^aPlacebo group represents patients given placebo. M group represents patients given metformin. PM group represents patients given pioglitazone metformin complex preparation.